Clincosm LogoSign in Get a demo

ALL

Showing 1 - 25 of 47
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Venetoclax Tablets Crushed and Dissolved Into a Solution

Not yet recruiting
  • Hematologic Malignancy
  • +18 more
  • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Nov 8, 2023

AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

Not yet recruiting
  • AML
  • +5 more
  • Infusion of CD34 selected hematopoietic stem cells
  • Birmingham, Alabama
    University of Alabama at Birmingham
Sep 14, 2023

ALL, MRD-positive, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Inotuzumab Ozogamicin)

Recruiting
  • ALL
  • +2 more
  • Inotuzumab Ozogamicin
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 14, 2023

ALL, Hodgkin Lymphoma, Cancer Trial in Memphis (Transcranial photobiomodulation (tPBM) - Mobile System)

Not yet recruiting
  • ALL
  • +3 more
  • Transcranial photobiomodulation (tPBM) - Mobile System
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Dec 6, 2022

All Trial (Review)

Withdrawn
  • All
  • Review
  • (no location specified)
Dec 2, 2022

All Trial in United States

Active, not recruiting
  • All
    • South San Francisco, California
    • +4 more
    Nov 22, 2022

    commd7 Gene Expression in ALL

    Not yet recruiting
    • ALL
    • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
    • (no location specified)
    Oct 20, 2022

    Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

    Not yet recruiting
    • Hematologic Malignancy
    • +10 more
    • Los Angeles, California
    • +28 more
    Jul 26, 2022

    ACL Injury, ALL Trial in Otwock (ACL reconstruction, ALL anatomic, ALL tenodesis)

    Recruiting
    • ACL Injury
    • ALL
    • ACL reconstruction
    • +2 more
    • Otwock, Mazowieckie, Poland
      Department of Orthopaedics and Traumatology, Centre of Postgradu
    Jul 13, 2022

    Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy

    Recruiting
    • DLBCL
    • +8 more
    • Cardiac MRI
    • Bonn, NRW, Germany
      University Hospital Bonn
    Jun 11, 2022

    All Trial in Pittsburgh

    Recruiting
    • All
      • Pittsburgh, Pennsylvania
        Children's Hospital of Pittsburgh
      May 16, 2022

      AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

      Recruiting
      • AML
      • +8 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      May 13, 2022

      ALL Trial in Spain (Prednisone, Vincristine, Daunorubicin)

      Active, not recruiting
      • ALL
      • Badalona, Spain
      • +9 more
      Feb 17, 2022

      AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Mixed Phenotype Acute Leukemia Trial in Palo Alto (T-allo10)

      Recruiting
      • AML - Acute Myeloid Leukemia
      • +5 more
      • T-allo10
      • Palo Alto, California
        Lucile Packard Children's Hospital
      Feb 2, 2022

      AML, Advanced MDS, ALL Trial in Chicago, New York (OTS167IV)

      Terminated
      • AML
      • +4 more
      • Chicago, Illinois
      • +1 more
      Nov 15, 2021

      ACL, Anterior Curciate Ligament, Anterolateral Ligament Trial in Lyon (Radiography)

      Recruiting
      • ACL
      • +4 more
      • Radiography
      • Lyon, France
        Hopital privé Jean Mermoz
      Nov 9, 2021

      B-precursor Acute Lymphoblastic Leukemia, ALL, GNR-084 Trial in Moscow, Saint Petersburg (GNR-084, 0.01 ng/kg, GNR-084, 0.1

      Recruiting
      • B-precursor Acute Lymphoblastic Leukemia
      • +2 more
      • GNR-084, 0.01 ng/kg
      • +5 more
      • Moscow, Russian Federation
      • +2 more
      Oct 25, 2021

      B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, ALL Trial in Boston (Venetoclax, Dexamethasone, Inotuzumab Ozogamicin)

      Recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Oct 19, 2021

      GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

      Recruiting
      • GVHD
      • +15 more
      • Boston, Massachusetts
        Massachusetts General Hospital
      Sep 30, 2021

      Acute Lymphoblastic Leukemia, ALL, Childhood, ALL Trial in Chicago (Ruxolitinib, Cyclophosphamide, Cytarabine)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • +2 more
      • Chicago, Illinois
        University of Chicago Medical Center
      Sep 14, 2021

      AML, ALL, MDS Trial in Germany (Peripheral blood stem cells)

      Recruiting
      • AML
      • +2 more
      • Peripheral blood stem cells
      • Bonn, Germany
      • +8 more
      Aug 25, 2021

      Family History in a Singaporean Healthy Population

      Recruiting
      • All
      • MeTree
      • Singapore, Singapore
        National Heart Centre of Singapore
      Aug 17, 2021

      Optical Genome Mapping in Hematological Malignancies

      Recruiting
      • MDS
      • +2 more
        • Brest, France
        • +3 more
        Aug 16, 2021

        ALL Trial in Chicago (IOHEXOL)

        Completed
        • ALL
        • Chicago, Illinois
          Ann & Robert H. Lurie Children's Hosptial of Chicago
        Jul 26, 2021

        ALL, B Cell Lymphoma, Leukemia Trial run by the NCI (Anti-Cluster of Differentiation (CD)19-Chimeric antigen receptor (CAR))

        Completed
        Has Results
        • ALL
        • +4 more
        • Anti-Cluster of Differentiation (CD)19-Chimeric antigen receptor (CAR)
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Aug 14, 2020